```html

Bacterial Gastrointestinal Infection – A Comprehensive Medical Guide

Overview

A bacterial gastrointestinal (GI) infection, often called bacterial food‑borne illness or bacterial enteritis, occurs when pathogenic bacteria colonize the stomach or intestines and cause inflammation. The most common culprits are Salmonella, Campylobacter, Escherichia coli (especially Shiga‑toxin–producing strains), Shigella, Vibrio cholerae, and Clostridioides difficile. These organisms are usually ingested through contaminated food, water, or contact with infected animals or people.

**Who is affected?** Anyone can develop a bacterial GI infection, but certain groups are more vulnerable:

• Young children (<5 years)
• Older adults (>65 years)
• People with weakened immune systems (e.g., HIV, chemotherapy, organ‑transplant recipients)
• Pregnant women
• Travelers to regions with lower sanitation standards

**Prevalence** – In the United States, the CDC estimates that bacterial food‑borne illnesses cause roughly 1 million illnesses, 5 000 hospitalizations, and 130 deaths each year. Worldwide, the WHO attributes >600 million cases of diarrheal disease annually to bacterial pathogens, making it a leading cause of morbidity, especially in low‑ and middle‑income countries.<sup>[1][2]</sup>

Symptoms

Symptoms usually appear 6 hours to 7 days after exposure, depending on the organism. The range can vary from mild, self‑limited illness to severe, life‑threatening disease.

Gastrointestinal Manifestations

• Diarrhea – watery, sometimes bloody; may be profuse.
• Abdominal cramping – often colicky and linked to bowel movements.
• Nausea & vomiting – may be the first sign.
• Fever – low‑grade (≤38 °C) to high (≥39 °C) especially with invasive bacteria.
• Loss of appetite – common in most infections.
• Urgent bowel movements – especially with Shigella or Campylobacter.

Systemic Signs (indicative of more severe disease)

• Dehydration: dry mouth, reduced urine output, dizziness.
• Blood in stool (hematochezia) – suggests invasive pathogens like E. coli O157:H7 or Shigella.
• Severe abdominal pain or rebound tenderness – possible perforation or toxic megacolon.
• Neurologic symptoms (e.g., confusion, seizures) – rare but may occur with C. perfringens or certain toxin‑producing strains.

Causes and Risk Factors

Common Bacterial Pathogens

Organism	Typical Sources	Key Clinical Features
Salmonella (non‑typhoidal)	Undercooked poultry, eggs, raw milk	Diarrhea + fever; may cause bacteremia
Campylobacter jejuni	Undercooked poultry, unpasteurized milk, contaminated water	Bloody diarrhea, severe cramps
Shiga‑toxin producing E. coli (STEC, e.g., O157:H7)	Undercooked beef (especially ground), raw veggies	Bloody diarrhea, hemolytic‑uremic syndrome (HUS)
Shigella	Person‑to‑person, contaminated salads, water	Fever, tenesmus, watery→bloody stools
Vibrio cholerae	Contaminated water/seafood in endemic areas	Profuse “rice‑water” diarrhea
Clostridioides difficile	Antibiotic‑disrupted gut flora, healthcare settings	Pseudomembranous colitis, toxin‑mediated diarrhea

Risk Factors

• Consumption of raw/undercooked animal products.
• Improper food handling (cross‑contamination, inadequate refrigeration).
• Travel to regions with poor sanitation.
• Recent use of broad‑spectrum antibiotics (predisposes to C. difficile).
• Chronic gastrointestinal conditions (IBD, IBS) that alter mucosal defenses.
• Living in crowded settings (day‑care centers, prisons, nursing homes).

Diagnosis

Prompt, accurate diagnosis guides therapy and prevents spread.

Clinical Evaluation

• Detailed history – recent food exposures, travel, antibiotic use, sick contacts.
• Physical exam – hydration status, abdominal tenderness, fever.

Laboratory Tests

• Stool culture – gold standard for most bacteria; isolates the organism and determines antimicrobial susceptibility.
• Stool PCR panels – multiplex tests (e.g., BioFire) detect DNA of multiple pathogens within hours; increasingly used in emergency departments.
• Stool toxin assays – for C. difficile (glutamate dehydrogenase antigen + toxin PCR) and STEC (Shiga toxin).
• Complete blood count (CBC) – leukocytosis may indicate invasive infection.
• Serum electrolytes & BUN/creatinine – assess dehydration and renal function.
• Blood cultures – reserved for severe cases or immunocompromised patients.

When to Perform Imaging?

Imaging (abdominal X‑ray, CT) is rarely needed but may be indicated if there is concern for complications such as perforation, abscess, or toxic megacolon.

Treatment Options

Treatment is individualized based on the pathogen, severity, patient comorbidities, and risk of complications.

Supportive Care – Cornerstone for All Patients

• Rehydration – oral rehydration salts (ORS) for mild‑moderate dehydration; IV isotonic fluids (e.g., 0.9 % saline) for severe dehydration or inability to tolerate oral intake.
• Electrolyte replacement – especially potassium and bicarbonate if prolonged diarrhea.
• Nutrition – early, bland diet (BRAT: bananas, rice, applesauce, toast) once vomiting subsides.

Antimicrobial Therapy

Pathogen	First‑line Antibiotic	Comments
Salmonella (non‑typhoidal)	Ciprofloxacin 500 mg PO q12h 5‑7 days	Reserved for high‑risk groups; many strains resistant to TMP‑SMX.
Campylobacter	Azithromycin 500 mg PO daily 3 days	Effective against fluoro‑resistant strains.
Shigella	Ciprofloxacin 500 mg PO bid 3 days	Alternative: azithromycin 500 mg daily.
STEC (e.g., O157:H7)	**No antibiotics**	Antibiotics increase HUS risk; provide only supportive care.
Vibrio cholerae	Doxycycline 300 mg PO single dose	Alternative: azithromycin 1 g PO single dose.
C. difficile	Oral vancomycin 125 mg q6h 10 days	Fidaxomicin is an alternative; avoid metronidazole as first line.

Antibiotics are **not** universally indicated; unnecessary use can prolong carriage and promote resistance.

Adjunctive Therapies

• Probiotics – strains such as Lactobacillus rhamnosus GG may reduce duration of diarrhea, especially after antibiotics.
• Anti‑motility agents (e.g., loperamide) – only in non‑invasive infections and when no fever; contraindicated in dysentery or C. difficile.

Living with Bacterial Gastrointestinal Infection

Day‑to‑Day Management

• Follow the rehydration schedule prescribed by your provider; aim for clear urine and no dizziness.
• Maintain a food diary – note foods that worsen symptoms; re‑introduce solids gradually.
• Practice good hand hygiene – wash hands with soap for at least 20 seconds after bathroom use and before eating.
• Limit caffeine, alcohol, and dairy (if lactose intolerant) until symptoms resolve.
• Take antibiotics exactly as directed; complete the full course even if you feel better.

Returning to Work/School

Most health agencies recommend staying home until at least 24 hours after the last unformed stool and fever‑free without antipyretics. For C. difficile, continue isolation precautions until negative toxin assay or per institution policy.

Prevention

• Food Safety
  • Cook poultry to an internal temperature of ≥74 °C (165 °F).
  • Heat ground beef to ≥71 °C (160 °F).
  • Wash fruits and vegetables under running water; avoid cross‑contamination with raw meat.
  • Refrigerate perishables within 2 hours (1 hour if ambient >32 °C).
• Water Safety
  • Drink only treated or bottled water when traveling to high‑risk regions.
  • Boil water for at least 1 minute if sanitation is uncertain.
• Personal Hygiene
  • Hand‑wash after using the toilet, changing diapers, and before preparing food.
  • Use alcohol‑based hand rubs when soap isn’t available.
• Antibiotic Stewardship
  • Only take antibiotics prescribed for a confirmed bacterial infection.
  • Avoid unnecessary broad‑spectrum agents to reduce C. difficile risk.
• Vaccination
  • Typhoid vaccine (for travelers to endemic areas).
  • Cholera vaccine (for high‑risk travelers).

Complications

If left untreated or inadequately managed, bacterial GI infections can lead to serious outcomes:

• Dehydration and electrolyte imbalance – may require hospital admission.
• Septicemia – especially with Salmonella or invasive Campylobacter.
• Hemolytic‑uremic syndrome (HUS) – a life‑threatening triad of hemolytic anemia, thrombocytopenia, and acute kidney injury, most often after STEC infection.
• Reactive arthritis – post‑infectious joint inflammation seen after Shigella, Salmonella, or Campylobacter.
• Guillain‑Barré syndrome – rare peripheral neuropathy following Campylobacter infection.
• Chronic inflammatory bowel disease exacerbation – bacterial triggers can flare ulcerative colitis or Crohn’s disease.

When to Seek Emergency Care

---

References

1. Centers for Disease Control and Prevention. Foodborne Illness. 2023. https://www.cdc.gov/foodborneburden/estimates.html
2. World Health Organization. Diarrhoeal disease. 2022. https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease
3. Mayo Clinic. Bacterial gastroenteritis. 2024. https://www.mayoclinic.org/diseases-conditions/bacterial-gastroenteritis/symptoms-causes/syc-20369999
4. Cleveland Clinic. Treatment of Campylobacter infection. 2023. https://my.clevelandclinic.org/health/diseases/21154-campylobacter
5. NIH National Institute of Diabetes and Digestive and Kidney Diseases. Clostridioides difficile Infection. 2023.
6. American College of Gastroenterology. Clinical Guidelines for Management of Acute Infectious Diarrhea. 2022.

```